BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caldera F, Mercer M, Samson SI, Pitt JM, Hayney MS. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity. Vaccine 2021;39 Suppl 1:A15-23. [PMID: 33422377 DOI: 10.1016/j.vaccine.2020.11.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Diaco M, Chang LJ, Seet B, Robertson CA, Chit A, Mercer M, Greenberg DP, Hollingsworth R, Samson SI. Introductory paper: High-dose influenza vaccine. Vaccine 2021;39 Suppl 1:A1-5. [PMID: 33549389 DOI: 10.1016/j.vaccine.2020.09.005] [Reference Citation Analysis]
2 Dauby N, Martin C. SARS-CoV-2 immunity and HIV infection: total recall? Lancet HIV 2021;8:e312-3. [PMID: 33933190 DOI: 10.1016/S2352-3018(21)00097-7] [Reference Citation Analysis]
3 Chan L, Alizadeh K, Alizadeh K, Fazel F, Kakish JE, Karimi N, Knapp JP, Mehrani Y, Minott JA, Morovati S, Rghei A, Stegelmeier AA, Vanderkamp S, Karimi K, Bridle BW. Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration. Vaccines (Basel) 2021;9:979. [PMID: 34579216 DOI: 10.3390/vaccines9090979] [Reference Citation Analysis]